2400
S. Polat-Cakir, A.S. Demir / Tetrahedron 67 (2011) 2396e2401
(d, JCeP¼4.2 Hz), 125.1 (d, J¼4.2 Hz), 108.5, 83.0 (d, JCeP¼173.8 Hz),
54.6 (d, J¼7.0 Hz, (CH3O)2P), 54.5 (d, J¼7.2 Hz, (CH3O)2P), 40.6; 31P
NMR (161 MHz, CDCl3): 18.13; IR (ATR technique, cmꢁ1): 2958,
1680, 1258, 1016; HRMS: calculated for C13H14ClO5P 316.0267 and
found 316.0266.
53.6 (d, JCeP¼5.8 Hz), 41.4, 19.2; 31P NMR (161 MHz, CDCl3): 22.08;
IR (ATR technique, cmꢁ1): 2961, 1672, 1600, 1309, 1231, 1019, 832;
HRMS: calculated for C8H13O5P 220.0500 and found 220.0491.
4.2.11. Dimethyl
(2-ethyl-4-oxo-3,4-dihydro-2H-pyran-2-yl)phos-
7.26 (d,
phonate 2k. Yellow oil; 1H NMR (CDCl3, 400 MHz):
d
4.2.6. Dimethyl (2-(2-chlorophenyl)-4-oxo-3,4-dihydro-2H-pyran-2-
J¼6.2 Hz, 1H), 5.43 (d, J¼6.2 Hz, 1H), 3.86 (d, J¼10.6 Hz, 3H), 3.83 (d,
J¼10.6 Hz, 3H), 2.98 (dd, J¼17.0 and 12.0 Hz, 1H), 2.71 (t, J¼17.0 Hz,
1H), 2.13e1.98 (m, 2H), 1.06 (t, J¼7.5 Hz, 3H); 13C NMR (CDCl3,
100 MHz): 188.9 (d, JCeP¼6.6 Hz), 159.8 (d, JCeP¼6.6 Hz), 106.2, 83.1
(d, JCeP¼171.6 Hz), 53.7 (d, J¼6.4 Hz), 53.5 (d, J¼6.5 Hz), 39.5, 26.8,
7.48 (d, JCeP¼5.1 Hz); 31P NMR (161 MHz, CDCl3): 22.59; IR (ATR
technique, cmꢁ1): 2960, 1675, 1601, 1252, 1228, 1021, 831; HRMS:
calculated for C9H15O5P 234.0657 and found 234.0649.
yl)phosphonate 2f. Yellow oil; 1H NMR (CDCl3, 400 MHz):
d
7.59e7.54 (m, 1H), 7.44e7.40 (m, 1H), 7.37 (dd, J¼6.0, 1.2 Hz, 1H),
7.35e7.27 (m, 2H), 5.42 (dd, J¼6.0, 1.1 Hz, 1H), 3.81 (d, J¼10.6 Hz,
3H), 3.74 (d, J¼10.6 Hz, 4H), 3.48 (dd, J¼16.8, 10.1 Hz, 1H); 13C NMR
(CDCl3, 100 MHz):
d
188.3 (d, JCeP¼11.8 Hz), 159.3 (d, JCeP¼12.2 Hz),
132.8 (d, J¼5.0 Hz), 132.7 (d, J¼1.9 Hz), 130.8, 130.2, 130.17 (d,
J¼3.6 Hz), 127.0 (d, J¼4.3 Hz), 108.6, 84.9 (d, JCeP¼173.8 Hz), 54.5 (d,
J¼7.1 Hz, (CH3O)2P), 54.3 (d, J¼7.1 Hz, (CH3O)2P), 41.4; 31P NMR
(161 MHz, CDCl3): 18.10; IR (ATR technique, cmꢁ1): 2981, 2923,
1681, 1599, 1510, 1250, 1014; HRMS: calculated for C13H14ClO5P
316.0267 and found 316.0276.
4.2.12. Dimethyl
(2-isopropyl-4-oxo-3,4-dihydro-2H-pyran-2-yl)
7.27 (d,
phosphonate 2l. Yellow oil; 1H NMR (CDCl3, 400 MHz):
d
J¼6.2 Hz, 1H), 5.41 (d, J¼6.2 Hz, 1H), 3.82 (d, J¼10.5 Hz, 3H), 3.79 (d,
J¼10.7 Hz, 3H), 2.91e2.74 (m, 2H), 2.54e2.39 (m, 1H), 1.09 (d,
J¼2.0 Hz, 3H), 1.08 (d, J¼2.0 Hz, 3H); 13C NMR (CDCl3, 100 MHz):
4.2.7. Diethyl (2-(4-fluorophenyl)-4-oxo-3,4-dihydro-2H-pyran-2-
yl)phosphonate 2g. Yellow oil; 1H NMR (CDCl3, 400 MHz):
d
7.49
d
189.1 (d, J¼3.6 Hz), 160.2 (d, J¼3.3 Hz), 106.0, 83.3 (d, J¼166.0 Hz),
(ddd, J¼8.9, 5.0, 2.2 Hz, 2H), 7.30 (dd, J¼6.1, 1.5 Hz, 1H), 7.07 (t,
J¼8.6 Hz, 2H), 5.38 (d, J¼6.1, 1H), 4.14e3.97 (m, 4H), 3.42 (dd,
J¼16.7, 11.0 Hz, 1H), 3.24 (dd, J¼16.7, 5.2 Hz, 1H), 1.26 (t, J¼7.0 Hz,
53.7 (d, J¼7.5 Hz), 53.2 (d, J¼7.4 Hz), 37.3, 33.4 (d, J¼3.2 Hz), 17.0 (d,
J¼2.7 Hz), 16.9 (d, J¼6.7 Hz); 31P NMR (161 MHz, CDCl3): 23.14; IR
(ATR technique, cmꢁ1): 2968, 1278, 1602, 1404, 1219, 1028, 1009;
HRMS: calculated for C10H17O5P 248.0814 and found 248.0808.
6H); 13C NMR (CDCl3,100 MHz):
d
188.0 (d, JCeP¼12.0 Hz),162.6 (dd,
J¼249.0 and 3.2 Hz), 159.2 (d, JCeP¼12.2 Hz), 128.8 (dd, J¼8.2 and
4.2 Hz), 115.2 (dd, J¼21.8 and 2.1 Hz), 108.2, 82.8 (d, JCeP¼174.8 Hz),
63.9 (d, J¼6.6 Hz, (CH3CH2O)2P), 63.8 (d, J¼5.8 Hz, (CH3CH2O)2P),
40.5, 16.0 (d, J¼5.2 Hz, (CH3CH2O)2P); 31P NMR (161 MHz, CDCl3):
16.18; IR (ATR technique, cmꢁ1): 2983, 1682, 1602, 1238, 1012;
HRMS: calculated for C15H18FO5P 328.0876 and found 328.0866.
4.3. General procedure for the HDA reactions of
benzoylphosphonate 1m with Danishefsky’s diene in the
presence of Lewis acids
To a solution of benzoylphosphonate 1m (200 mg, 1 equiv) in
either DCM or toluene (2 mL) was added Lewis acid (either 1.1 equiv
or 1.0 equiv) at ꢁ78 ꢀC under argon atmosphere. After stirring for
10 min, Danishefsky’s diene (2 equiv) was added to the reaction
mixture at the same temperature as the time indicated in Table 2.
TFA was added slowly to the reaction mixture and stirred for 30 min.
The reaction mixture was carefully quenched byadding few drops of
water at 0 ꢀC and then filtrated over Celite and concentrated. The
crude product was purified by flash column chromatography.
4.2.8. Dimethyl (2-(2-fluorophenyl)-4-oxo-3,4-dihydro-2H-pyran-2-
yl)phosphonate 2h. Yellow oil; 1H NMR (CDCl3, 400 MHz):
d
7.52e7.47 (m, 1H), 7.38e7.31 (m, 2H), 7.18 (t, J¼7.6 Hz, 1H), 7.08
(dd, J¼12.4, 8.3 Hz, 1H), 5.40 (dd, J¼6.1, 1.0 Hz, 1H), 3.78 (d,
J¼10.6 Hz, 3H), 3.76 (d, J¼10.6 Hz, 3H), 3.53 (dd, J¼16.5 and 7.0 Hz,
1H), 3.42 (ddd, J¼16.5, 10.4, 1.7 Hz, 1H); 13C NMR (CDCl3, 100 MHz):
d
188.3 (d, JCeP¼12.1 Hz), 160.4 (dd, J¼251.6 and 4.2 Hz), 159.2 (d,
JCeP¼12.0 Hz), 131.1 (dd, J¼8.9, 2.8 Hz), 129.3 (dd, J¼3.7, 2.7 Hz),
124.2 (t, J¼2.9 Hz), 120.9 (dd, J¼10.0, 1.4 Hz), 117.1 (dd, J¼24.2,
2.1 Hz),108.5, 83.0 (dd, JCeP¼175.3, 4.2 Hz), 54.5 (d, J¼7.0 (CH3O)2P),
54.4 (d, J¼7.1 (CH3O)2P), 40.8 (d, J¼8.6 Hz); 31P NMR (161 MHz,
CDCl3): 18.03; IR (ATR technique, cmꢁ1): 2960, 1682, 1599, 1242,
1013; HRMS: calculated for C13H14FO5P 300.0562 and found
300.0560.
4.3.1. Dimethyl (4-oxo-2-phenyl-3,4-dihydro-2H-pyran-2-yl)phos-
phonate 2m. Yellow oil; 1H NMR (CDCl3, 400 MHz):
d 7.52e7.49 (m,
2H), 7.41e7.34 (m, 3H), 7.31 (dd, J¼6.1 and 1.4 Hz, 1H), 5.37 (d,
J¼6.1 Hz, 1H), 3.71 (d, J¼10.6 Hz, 3H), 3.65 (d, J¼10.6 Hz, 3H), 3.43
(dd, J¼16.7 and 11.1 Hz, 1H), 3.29 (ddd, J¼16.7, 5.6 and 0.7 Hz, 1H);
13C NMR (CDCl3, 100 MHz):
d
188.1 (d, J¼12.4 Hz), 159.3 (d,
J¼12.3 Hz), 133.7, 128.9 (d, J¼2.3 Hz), 128.5 (d, J¼2.0 Hz), 126.9 (d,
J¼4.3 Hz), 108.4, 83.5 (d, J¼174.5 Hz), 54.5 (t, J¼7.4 Hz), 40.6; 31P
NMR (161 MHz, CDCl3): 18.07; IR (ATR technique, cmꢁ1): 2959,
1675, 1597, 1243, 1015, 832; HRMS: calculated for C13H15O5P
282.0657 and found 282.0654. Determination of enantiomeric ex-
cess (ee) values for racemic 2m: Chiralcel OC, hexane/IPA¼95:5,
flow¼1 mL/min t¼12.29 and 13.34 min. The asymmetric compound
2m was prepared according to the procedure in literature (Ref. 6).
(S,S)-2,20-Methylenebis(4-tert-butyl-2-oxazoline) was used as the
ligand. Determination of enantiomeric excess (ee) values for
asymmetric 2m: Chiralcel OC, hexane/IPA¼95:5, flow¼1 mL/min
t¼12.11 and 13.80 min.
4.2.9. Dimethyl (4-oxo-2-(4-(trifluoromethyl)phenyl)-3,4-dihydro-
2H-pyran-2-yl)phosphonate 2i. Yellow oil; 1H NMR (CDCl3,
400 MHz):
d
7.65 (br t, J¼10 Hz, 4H), 7.33 (dd, J¼6.1, 1.3 Hz, 1H), 5.40
(dd, J¼6.1 and 0.8 Hz,1H), 3.77 (d, J¼10.6 Hz, 3H), 3.70 (d, J¼10.6 Hz,
3H), 3.47 (dd, J¼16.7 and 11.3 Hz, 1H), 3.28 (dd, J¼16.7, 5.6 Hz, 1H);
13C NMR (CDCl3, 100 MHz):
d
187.6 (d, JCeP¼12.0 Hz), 159.2 (d,
JCeP¼12.0 Hz), 138.4, 131.2 (dq, J¼32.8, 2.9 Hz), 127.4 (d, J¼4.1 Hz),
125.5 (t, J¼3.2 Hz), 123.7 (dd, J¼272.2 and 1.2 Hz), 108.8, 83.4 (d,
J¼173.9 Hz), 54.8 (d, J¼6.8 Hz, (CH3O)2P), 54.7 (d, J¼6.7 Hz,
(CH3O)2P), 40.8; 31P NMR (161 MHz, CDCl3): 17.96; IR (ATR tech-
nique, cmꢁ1): 3283, 2969, 2911, 1675, 1178, 1056, 1009; HRMS:
calculated for C14H14F3O5P 350.0531 and found 350.0532.
4.4. General procedure for the HDA reactions of acyl
phosphonates with Brassard’s diene in the presence of
Me2AlCl (3m, 3c,d and 3k)
4.2.10. Dimethyl (2-methyl-4-oxo-3,4-dihydro-2H-pyran-2-yl)phos-
phonate 2j. Yellow oil; 1H NMR (CDCl3, 400 MHz):
d 7.26 (d,
J¼6.2 Hz, 1H), 5.44 (d, J¼6.2 Hz, 1H), 3.88 (d, J¼10.5 Hz, 6H), 3.08
(dd, J¼16.7 and 12.1 Hz, 1H), 2.55 (dd, J¼16.7 and 11.5 Hz, 1H), 1.65
To a solution of acyl phosphonate (200 mg, 1 equiv) in DCM
(2 mL) was added Me2AlCl (1.1 equiv) at ꢁ78 ꢀC under argon at-
mosphere. After stirring for 10 min, freshly prepared Brassard’s
(d, J¼15.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz):
d 188.2 (d,
JCeP¼9.9 Hz), 159.3 (d, JCeP¼9.4 Hz), 105.9, 79.9 (d, JCeP¼176.3 Hz),